granzyme K Antibodies

Santa Cruz Biotechnology provides a broad selection of granzyme K monoclonal antibodies for investigating the role of this serine protease in immune responses. Granzyme K monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Granzyme K is primarily produced by cytotoxic T cells and natural killer cells, playing a crucial role in the induction of apoptosis in target cells. The function of granzyme K is vital for the immune system's ability to eliminate infected or malignant cells, making it an important focus in cancer research and immunology. Understanding granzyme K mechanisms can provide insights into therapeutic strategies for enhancing immune responses against tumors and infections. Granzyme K monoclonal antibodies enable detailed analysis of protein expression, localization, and interactions in various experimental settings. Researchers can utilize granzyme K monoclonal antibodies to examine cellular pathways involved in immune regulation and cell death. The high specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies for granzyme K support researchers in advancing our understanding of immune system function and potential therapeutic applications.